Trademarkia Logo

Canada

C$
Trademark Search in Canada
DYRUPEG

View On IC.GC.CA

DYRUPEG
FORMALIZED

on 15 Mar 2022

Last Applicant/ Owned by

AURO PHARMA INC.

3700 Steeles Ave. W., Suite 402Woodbridge

ONTARIO

CA

L4L8K8

Serial Number

2172657 filed on 15th Mar 2022

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 16001 FIRST CANADIAN PLACE100 KING STREET WESTTORONTO

ONTARIO

CA

M5X1G5

DYRUPEG

Trademark usage description

pegfilgrastim injection products used to reduce the chance of infection in people who have certain types of cancer and are receiving chemotherapy medi Read More

Classification Information

Class [005]
Pegfilgrastim injection products used to reduce the chance of infection in people who have certain types of cancer and are receiving chemotherapy medications that may decrease the number of neutrophils; Medication used in the reduction in the duration of neutropenia and the incidence of febrile neutropenia in adult patients treated with cytotoxic chemotherapy for malignancy (with the exception of chronic myeloid leukaemia and myelodysplastic syndromes); Biopharmaceuticals; Biological preparations for medical use; Pharmaceutical preparations for medical use; Pharmacological preparations for medical use; Gene-based and cellular biologics for medical use; biochemical preparations for medical use; biosimilars for medical use; Injectable pharmaceutical solutions for the prevention of infection in cancer patients; Pharmaceutical; Medical pharmaceuticals

Classification kind code

11

Class [010]
Injection needles for medical purposes; Syringes for medical purposes and for injections; Medical devices; medical apparatus for delivery of pharmaceuticals

Classification kind code

11

Mark Details

Serial Number

2172657

Mark Type

Trademark

Legal History

Action TakenStatus
Submitted for opposition 48
on 6th Sept 2023		Agent Changed
Submitted for opposition 287
on 19th May 2022		Pre-Assessment Letter Sent
Submitted for opposition 30
on 15th Mar 2022		Filed
Submitted for opposition 1
on 15th Mar 2022		Created
Submitted for opposition 31
on 15th Mar 2022		Formalized